Heinz Christoph Maeusli
CIK 1788919 · last filed 2026-05-18
Heinz Christoph Maeusli is a corporate insider who has filed 22 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for LNTH, was dated May 18, 2026. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.14M
2
22
-$1.31M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNTH | Director | 30,014 | $104.52 | $3.14M | -$1.31M | 19 | 2026-05-18 |
| PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Director | — | — | — | $0 | 2 | 2019-12-17 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | LNTH | Grant (A) | +4,137 | $0 | EDGAR |
| 2025-05-16 | LNTH | Grant (A) | +2,537 | $0 | EDGAR |
| 2024-05-30 | LNTH | Mixed | −892 | -$1.17M | EDGAR |
| 2024-05-13 | LNTH | Grant (A) | +2,635 | $0 | EDGAR |
| 2023-05-15 | LNTH | Grant (A) | +2,012 | $0 | EDGAR |
| 2022-05-12 | LNTH | Grant (A) | — | $0 | EDGAR |
| 2022-05-10 | LNTH | Grant (A) | +2,180 | $0 | EDGAR |
| 2021-05-12 | LNTH | Grant (A) | +8,513 | $0 | EDGAR |
| 2021-03-09 | LNTH | Buy (P) | +1,000 | $18.6K | EDGAR |
| 2021-03-02 | LNTH | Buy (P) | +1,000 | $18.0K | EDGAR |